Literature DB >> 19497063

Everolimus-induced pneumonitis: report of the first case in a liver transplant recipient and review of treatment options.

Jörg Schrader, Martina Sterneck, Hans Klose, Ansgar W Lohse, Björn Nashan, Lutz Fischer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19497063     DOI： 10.1111/j.1432-2277.2009.00900.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN： 0934-0874            Impact factor:   3.782


× No keyword cloud information.
  8 in total

1.  Everolimus-related organizing pneumonia: a report establishing causality.

Authors:  Justine Frija; Dominique Joly; Bertrand Knebelmann; Daniel Dusser; Pierre-Régis Burgel
Journal:  Invest New Drugs       Date:  2010-12-29       Impact factor: 3.850

2.  [Intermittent fever under iatrogenic immunosuppression].

Authors:  M Bönstrup; S Schmiedel; A W Lohse
Journal:  Internist (Berl)       Date:  2012-02       Impact factor: 0.743

3.  Interstitial pneumonitis is a frequent complication in liver transplant recipients treated with sirolimus.

Authors:  A Morcos; S Nair; M P Keane; N G McElvaney; P A McCormick
Journal:  Ir J Med Sci       Date:  2012-01-15       Impact factor: 1.568

4.  Multiple indications for everolimus after liver transplantation in current clinical practice.

Authors:  Itxarone Bilbao; Cristina Dopazo; Jose Lazaro; Lluis Castells; Mireia Caralt; Gonzalo Sapisochin; Ramon Charco
Journal:  World J Transplant       Date:  2014-06-24

Review 5.  Systemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitors.

Authors:  Gianluigi Zaza; Paola Tomei; Paolo Ria; Simona Granata; Luigino Boschiero; Antonio Lupo
Journal:  Clin Dev Immunol       Date:  2013-09-19

Review 6.  Interstitial Lung Disease Associated with mTOR Inhibitors in Solid Organ Transplant Recipients: Results from a Large Phase III Clinical Trial Program of Everolimus and Review of the Literature.

Authors:  Patricia Lopez; Sven Kohler; Seema Dimri
Journal:  J Transplant       Date:  2014-12-18

7.  STAT3 Polymorphism Associates With mTOR Inhibitor-Induced Interstitial Lung Disease in Patients With Renal Cell Carcinoma.

Authors:  Kazuhiro Yamamoto; Takeshi Ioroi; Kazuaki Shinomiya; Ayaka Yoshida; Kenichi Harada; Masato Fujisawa; Tomohiro Omura; Yasuaki Ikemi; Shunsaku Nakagawa; Atsushi Yonezawa; Osamu Ogawa; Kazuo Matsubara; Takuya Iwamoto; Kohei Nishikawa; Sayaka Hayashi; Daichi Tohara; Yoji Murakami; Takanobu Motoshima; Hirofumi Jono; Ikuko Yano
Journal:  Oncol Res       Date:  2022-01-11       Impact factor: 4.938

8.  Everolimus associated interstitial pneumonitis in a liver transplant patient.

Authors:  Atif S Siddiqui; Janice L Zimmerman
Journal:  Respir Med Case Rep       Date:  2016-06-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.